Aclarion, Inc.

ACON

Aclarion, Inc.

ACON

Insider Sentiment (TTM):

Last Purchase:2026-05-12Last Sale:-Shares Purchased (TTM):16,025Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:112,575Shares Outstanding:2,129,871Institutional Ownership Pct.:5.29%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Cash	-	-	-	-	-	-	-	-	-	-	-	0
Assets
Cash And Cash Equivalents At Carrying Value	16	19	12	11	13	15	0	1	1	2	1	-
Restricted Cash	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current
Assets Current	17	19	12	12	13	15	1	2	2	3	1	0
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	1	1	0	0	0
Other Assets Current	0	0	0	0	0	-	0	-	-	-	-	-
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Assets Noncurrent
Assets Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Intangible Assets Net Excluding Goodwill	1	1	1	1	1	1	1	1	1	1	1	1
Assets	18	21	14	13	15	16	2	3	3	4	2	2
Liabilities And Stockhold…
Accounts Payable Current	1	1	0	0	0	1	1	0	0	0	1	1
Accrued Liabilities And Other Liabilities	0	0	1	0	0	0	1	0	0	0	1	0
Liabilities Current
Liabilities Current	1	1	1	1	1	1	1	1	1	1	3	2
Other Notes Payable Current	-	-	-	-	-	-	0	0	1	1	1	1
Derivative Liabilities Current	0	0	0	-	-	-	0	0	0	0	0	0
Liabilities	1	1	1	1	1	1	1	1	1	1	-	-
Common Stock Value	0	0	-	-	-	-	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital	81	81	71	69	69	69	52	52	50	49	44	42
Stockholders Equity	17	20	13	13	14	16	1	3	2	3	-1	-1
Retained Earnings Accumulated Deficit	-64	-61	-58	-57	-55	-53	-51	-49	-48	-47	-44	-43
Liabilities And Stockholders Equity	18	21	14	13	15	16	2	3	3	4	2	2
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	2	2	1	1	1	1	1	10	8	7	0	1
Shares Outstanding	2	2	1	1	1	1	1	10	8	7	1	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	8.84%	-5.79%	-31.40%	-	-	-	-	-	-	-	-	-
2025	-0.43%	7.97%	1.38%	-0.25%	2.61%	8.33%	-10.95%	-27.77%	-51.99%	-2.71%	-4.07%	7.53%
2024	6.83%	4.68%	4.32%	-11.54%	-17.31%	-11.06%	-3.53%	75.29%	-87.53%	-20.32%	-26.45%	-17.48%
2023	-	-	-	11.11%	18.89%	-24.44%	-35.29%	-43.75%	-56.25%	-9.09%	-1.52%	-9.09%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	16.20	19.65	14.81	17.01	23.81	21.68	0.71	2.80	1.28	2.08	0.40	0.15
Quick Ratio	15.77	19.35	14.43	16.43	22.98	21.14	0.56	1.97	0.83	1.77	0.33	0.08
Working Capital	15.76M	18.39M	11.56M	11.20M	12.88M	14.46M	-329.15K	1.22M	405.11K	1.32M	-1.90M	-2.01M
Leverage & Debt
Debt to Equity	0.06	0.05	0.07	0.06	0.04	0.04	1.19	0.27	0.88	0.49	-4.38	-2.86
Interest Coverage TTM	-	-	-	-	-	-	-16.42	-6.63	-5.25	-5.27	-8.02	-21.63
Debt Ratio	0.06	0.05	0.06	0.05	0.04	0.04	0.54	0.21	0.47	0.33	1.30	1.54
Efficiency & Turnover
Asset Turnover TTM	0.01	0.00	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.02	0.03	0.03
Days Sales Outstanding TTM	106.95	140.03	115.69	132.43	117.80	121.61	126.11	141.22	101.75	104.45	77.06	101.28
Receivables Turnover TTM	3.41	2.61	3.16	2.76	3.10	3.00	2.89	2.58	3.59	3.49	4.74	3.60
Per Share Metrics
Diluted EPS TTM	-3.74	-3.78	-13.61	-12.58	-12.02	-30.26	-7.42	-6.02	-6.50	-10.18	-79,215.71	-8.85
Free Cash Flow Per Share TTM	-3.26	-3.46	-13.65	-6.94	-6.92	-26.55	-5.87	-5.16	-5.71	-8.38	-60,749.50	-7.85
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	21.75%	19.35%	9.02%	-7.83%	-26.37%	-62.38%	-85.15%	-69.45%	-51.53%	-29.48%	-0.43%	12.51%
Operating Profit Margin TTM	-11,592.28%	-10,975.24%	-9,312.55%	-10,173.70%	-10,056.73%	-10,493.70%	-12,057.23%	-9,805.77%	-8,711.11%	-8,276.75%	-6,466.48%	-5,577.40%
Net Profit Margin TTM	-10,978.61%	-10,336.25%	-9,560.69%	-10,859.76%	-11,121.10%	-12,157.18%	-15,293.78%	-12,742.89%	-10,937.65%	-10,203.53%	-6,513.41%	-5,609.19%
Growth Metrics
Net Revenue Growth (1Y)	33.07%	42.63%	65.62%	36.91%	16.69%	-9.07%	-39.36%	-41.41%	-35.23%	-21.90%	24.75%	-
Net Income Growth (1Y)	31.37%	21.27%	3.54%	16.68%	18.64%	8.34%	42.38%	33.10%	10.21%	-17.69%	-34.38%	-
EPS Growth (1Y)	-68.93%	-87.51%	83.51%	108.97%	84.98%	197.31%	-99.99%	-31.99%	-37.13%	-32.16%	403,802.94%	-
Valuation Metrics
P/E TTM	-0.77	-0.87	-0.34	-0.60	-0.63	-0.36	-175.64	-274.87	-398.08	-293.27	-0.37	-5,328.18
P/B TTM	0.42	0.35	0.19	0.35	0.31	0.15	1,266.15	687.87	1,430.34	717.19	-2.47	-30,366.51
P/S TTM	84.65	89.43	32.32	64.72	69.62	43.39	26,862.01	35,026.28	43,540.48	29,924.06	23.80	298,867.90
Market Cap	7.09M	6.96M	2.45M	4.37M	4.38M	2.37M	1.23B	1.73B	2.35B	1.80B	1.79M	25.14B
Enterprise Value	-9.22M	-12.07M	-9.59M	-7.00M	-8.47M	-12.39M	1.23B	1.73B	2.35B	1.79B	2.01M	25.14B
Calculated Values
Free Cash Flow TTM	-8.03M	-7.37M	-7.26M	-4.04M	-4.03M	-5.82M	-5.54M	-5.38M	-5.18M	-5.04M	-3.77M	-4.18M
Net Debt	-16.31M	-19.03M	-12.04M	-11.37M	-12.85M	-14.76M	-463.66K	-1.32M	-1.18M	-2.14M	212.87K	-171.45K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-12Purchase

Owner: Breidbart, Scott

Title: -

Shares: 5,664

Price/Share: $3.18

Value: $18,011.52

Shares Owned: 5,664

Relationship: Director

Ownership: Direct

2026-05-11Purchase

Owner: Neal, David K

Title: -

Shares: 2,500

Price/Share: $3.10

Value: $7,750.00

Shares Owned: 2,502

Relationship: Director

Ownership: Direct

2026-05-11Purchase

Owner: Ness, Brent

Title: Chief Executive Officer

Shares: 6,289

Price/Share: $3.18

Value: $19,999.02

Shares Owned: 6,300

Relationship: Director,Officer

Ownership: Direct

2026-05-06Purchase

Owner: Wesemann, William

Title: -

Shares: 1,562

Price/Share: $3.30

Value: $5,154.60

Shares Owned: 1,563

Relationship: Director

Ownership: Direct

2025-11-26Purchase

Owner: Ness, Brent

Title: Chief Executive Officer

Shares: 10

Price/Share: $6.20

Value: $62.00

Shares Owned: 11

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-12	Breidbart, Scott	Director	-	Direct	Purchase	5,664	3.18	$18,011.52	5,664	4
2026-05-11	Neal, David K	Director	-	Direct	Purchase	2,500	3.10	$7,750.00	2,502	4
2026-05-11	Ness, Brent	Director,Officer	Chief Executive Officer	Direct	Purchase	6,289	3.18	$19,999.02	6,300	4
2026-05-06	Wesemann, William	Director	-	Direct	Purchase	1,562	3.30	$5,154.60	1,563	4
2025-11-26	Ness, Brent	Director,Officer	Chief Executive Officer	Direct	Purchase	10	6.20	$62.00	11	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

5.29%

Inst. Shares: 112,575

Shares Outstanding: 2,129,871

2025-12-31

3.27%

Inst. Shares: 17,424

Shares Outstanding: 532,036

2025-09-30

3.85%

Inst. Shares: 22,399

Shares Outstanding: 582,371

2025-06-30

0.31%

Inst. Shares: 1,815

Shares Outstanding: 582,371

2025-03-31

0.03%

Inst. Shares: 67

Shares Outstanding: 219,366

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	112,575	2,129,871	5.29%
2025-12-31	17,424	532,036	3.27%
2025-09-30	22,399	582,371	3.85%
2025-06-30	1,815	582,371	0.31%
2025-03-31	67	219,366	0.03%
2024-12-31	74,390	943,000	7.89%
2024-09-30	158,818	1,043,000	15.23%
2024-06-30	165,269	908,000	18.20%
2024-03-31	30,477	602,000	5.06%
2023-12-31	595,229	62	-
2023-09-30	510,317	532,928	95.76%
2023-06-30	477,879	517,979	92.26%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Aclarion, Inc. (ACON) — SEC Financial Statements & Analysis

Aclarion, Inc. (ACON) is a services-medical laboratories company, incorporated in DE. Aclarion, Inc. trades on Nasdaq as: ACON, ACONW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Aclarion, Inc. reported a 33.07% year-over-year revenue growth, a Gross Profit Margin of 21.75% (TTM), a Debt-to-Equity ratio of 0.06x, a Price-to-Sales (P/S) ratio of 84.65x (TTM), a Price-to-Book (P/B) ratio of 0.42x (TTM), at a market cap of $7.09M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 33.07%
Gross Profit Margin TTM: 21.75%
Debt To Equity: 0.06x
P/S TTM: 84.65x
P/B TTM: 0.42x
Market Cap: $7.09M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Aclarion, Inc. in?

Aclarion, Inc. (ACON) operates in the Services-Medical Laboratories industry.

What is ACON's market cap?

Aclarion, Inc. (ACON) has a market capitalization of $7.09M as of 2026-06-30.

What exchange does ACON trade on?

Aclarion, Inc. (ACON) trades on the Nasdaq.

Where is Aclarion, Inc. incorporated?

Aclarion, Inc. is incorporated in DE.

Aclarion, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Aclarion, Inc. (ACON) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Medical Laboratories

Wall Street's data.
Main Street's price.

Aclarion, Inc. (ACON) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Services-Medical Laboratories

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.